Pharmacogenetics Firm Sued for Fraud

Comments (0)

A pharmacogenetics firm from New Orleans, Renaissance Rx, is facing allegations that the company funneled fraudulent and illegal Medicare tests through another doctor’s office. Renaissance Rx has faced a number of legal issues, including an investigation from the federal government. 

A doctor specializing in internal medicine contracted with Renaissance Rx to enroll patients in a study that was designed to determine a patient’s genetic disposition to certain drugs. The doctor says that after only 30 tests, he stopped his involvement in the study because of concerns over the legality of the study, and his opinion that it was not following guidelines and regulations regarding clinical trials.

Later, the company allegedly fabricated the doctor’s signature and attached it to the forms of thousands of patients who were involved in the study, because the results were worth an estimated $10 million. He also says that as late as eight months after he discontinued his involvement with the company his name was still being used on promotional materials. He sued the company for the misappropriation of his name. In addition to the lawsuit, Renaissance Rx is under investigation for Medicare fraud.

Unfortunately, companies such as Renaissance Rx that are supposed to help to test prescription drugs to make them safer for the general public are often more concerned about making money, even if that means breaking federal and state laws. When a pharmaceutical company manufactures an unsafe drug, it can be held liable for damages if someone is harmed by the drug.

If you believe that you have been harmed by a dangerous prescription drug, call the defective drug attorneys at Kennedy Hodges at 855-947-0707, or visit us on Twitter. We will provide a free consultation to you on your case, and you pay no fees unless we obtain a recovery for you. 

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.